Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer

2.50
Hdl Handle:
http://hdl.handle.net/2436/621046
Title:
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer
Authors:
James, Nicholas D.; Spears, Melissa R.; Clarke, Noel W.; Dearnaley, David P.; Mason, Malcolm D.; Parker, Christopher C.; Ritchie, Alastair W. S.; Russell, J. Martin; Schiavone, Francesca; Attard, Gerhardt; de Bono, Johann S.; Birtle, Alison; Engeler, Daniel S.; Elliott, Tony; Matheson, David; O’Sullivan, Joe; Pudney, Delia; Srihari, Narayanan; Wallace, Jan; Barber, Jim; Syndikus, Isabel; Parmar, Mahesh K. B.; Sydes, Matthew R.
Citation:
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer 2016, 2 (3):348 JAMA Oncology
Publisher:
American Medical Association
Journal:
JAMA Oncology
Issue Date:
1-Mar-2016
URI:
http://hdl.handle.net/2436/621046
DOI:
10.1001/jamaoncol.2015.4350
Additional Links:
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.4350
Type:
Article
Language:
en
ISSN:
2374-2437
Sponsors:
The Medical Research Council sponsored the study and was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Funding was also provided by Cancer Research UK, Astellas, Janssen, Novartis, Sanofi-Aventis, and Pfizer, none of which were directly involved in the research.
Appears in Collections:
FEHW

Full metadata record

DC FieldValue Language
dc.contributor.authorJames, Nicholas D.en
dc.contributor.authorSpears, Melissa R.en
dc.contributor.authorClarke, Noel W.en
dc.contributor.authorDearnaley, David P.en
dc.contributor.authorMason, Malcolm D.en
dc.contributor.authorParker, Christopher C.en
dc.contributor.authorRitchie, Alastair W. S.en
dc.contributor.authorRussell, J. Martinen
dc.contributor.authorSchiavone, Francescaen
dc.contributor.authorAttard, Gerhardten
dc.contributor.authorde Bono, Johann S.en
dc.contributor.authorBirtle, Alisonen
dc.contributor.authorEngeler, Daniel S.en
dc.contributor.authorElliott, Tonyen
dc.contributor.authorMatheson, Daviden
dc.contributor.authorO’Sullivan, Joeen
dc.contributor.authorPudney, Deliaen
dc.contributor.authorSrihari, Narayananen
dc.contributor.authorWallace, Janen
dc.contributor.authorBarber, Jimen
dc.contributor.authorSyndikus, Isabelen
dc.contributor.authorParmar, Mahesh K. B.en
dc.contributor.authorSydes, Matthew R.en
dc.date.accessioned2018-01-30T09:31:16Z-
dc.date.available2018-01-30T09:31:16Z-
dc.date.issued2016-03-01-
dc.identifier.citationFailure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer 2016, 2 (3):348 JAMA Oncologyen
dc.identifier.issn2374-2437-
dc.identifier.doi10.1001/jamaoncol.2015.4350-
dc.identifier.urihttp://hdl.handle.net/2436/621046-
dc.description.sponsorshipThe Medical Research Council sponsored the study and was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Funding was also provided by Cancer Research UK, Astellas, Janssen, Novartis, Sanofi-Aventis, and Pfizer, none of which were directly involved in the research.en
dc.language.isoenen
dc.publisherAmerican Medical Associationen
dc.relation.urlhttp://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.4350en
dc.rightsArchived with thanks to JAMA Oncologyen
dc.subjectfailure-free survivalen
dc.subjectradiotherapyen
dc.subjectprostate canceren
dc.subjectnon-metastatic prostate canceren
dc.subjectSTAMPEDEen
dc.titleFailure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Canceren
dc.typeArticleen
dc.identifier.journalJAMA Oncologyen
dc.contributor.institutionWarwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom-
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom-
dc.contributor.institutionDepartment of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom-
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom-
dc.contributor.institutionVelindre Hospital, Cardiff, United Kingdom-
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom-
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom-
dc.contributor.institutionInstitute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom-
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom-
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom-
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom-
dc.contributor.institutionRoyal Preston Hospital, Preston, United Kingdom-
dc.contributor.institutionCantonal Hospital St Gallen, St Gallen, Switzerland-
dc.contributor.institutionGreater Manchester Group, Manchester, United Kingdom-
dc.contributor.institutionLeeds Beckett University, Leeds, United Kingdom-
dc.contributor.institutionBelfast City Hospital, Belfast, United Kingdom-
dc.contributor.institutionSingleton Hospital, Swansea, United Kingdom-
dc.contributor.institutionRoyal Shrewsbury Hospital, Shrewsbury, United Kingdom-
dc.contributor.institutionBeatson West of Scotland Cancer Centre, Glasgow, United Kingdom-
dc.contributor.institutionVelindre Hospital, Cardiff, United Kingdom-
dc.contributor.institutionCCO Liverpool Warrington Aintree, Liverpool, United Kingdom-
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom-
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom-
All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.